New, exclusive capability will allow antibody discovery clients to access more hits and more screening data than competing technologies Antibody Solutions, a leading provider of fit-for-purpose ...
After decades of trials into pathways that ultimately failed in Sjögren’s disease, recent efforts targeting B cells have ...
Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company", Stock Code: 9887.HK) announced that the U.S. Food and Drug Administration (FDA) has approved its first-in-human Investigational New ...
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today ...
A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the long-term, drug-free remission from autoimmune diseases observed after treatment, according to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback